Product Description
Mechanisms of Action:
Novel Mechanism: No
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Cardiff and Vale University Health Board
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01143961 |
09/MRE09/54 | N/A |
Completed |
Acute Respiratory Distress Syndrome|Pneumonia |
2011-01-01 |
2020-06-29 |
Primary Endpoints |
Recent News Events
Date |
Type |
Title |
|---|